|
SAGE Sage Therapeutics Inc 1597553 |
| Balance Sheet |
|
Current Assets
|
531,301,000 |
|
Assets
|
547,222,000 |
|
Current Liabilities
|
71,615,000 |
|
Liabilities
|
82,133,000 |
|
Equity
|
465,089,000 |
|
Shares Out
|
167,287,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-267,194,000 |
|
Investing Cash Flow
|
266,678,000 |
| Market Analysis |
Market Cap
|
29,178,152 |
|
Price
|
0.18 |
|
BVPS
|
30.85 |
|
PB
|
0.26 |
|
EPS
|
-0.10 |
|
PS
|
0.11 |
|
FCF
|
-516,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SAGE documents filed with the SEC.
SAGE Filings
Clear
